KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹0.99 Cr |
| Mar2023 | ₹-20 Cr |
| Mar2022 | ₹123 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 2,515.57 | |
| Mar2024 | ₹0.99 Cr | Positive | |
| Mar2023 | ₹-20 Cr | Negative | |
| Mar2022 | ₹123 Cr | Positive | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹773.3 Cr | -0.9% | -9.6% | -42.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -0.9% |
-9.6% |
-42.7% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses